*If you receive Abilify Maintena, your administration fee may be covered through Otuska Patient Support
A quick injection designed to support energy, clarity, and everyday wellness
Individuals most likely to benefit include: Those with pernicious anemia People with gastrointestinal disorders (e.g., Crohns disease, celiac disease, chronic gastritis) Patients following bariatric (weight loss) surgery Older adults with absorption difficulties Strict vegetarians or vegans at risk for deficiency People taking medications that can decrease vitamin B12 levels Laboratory testing usually confirms B12 deficiency before starting injections
Those patients with a reduction of UA to levels below 6 mg/dL had the lowest drop in glomerular filtration rate throughout follow-up
Many individuals interested in active lifestyles, recovery optimization, and long-term wellness explore peptide-based recovery support under appropriate provider guidance
BPC-157 lacks FDA approval and remains investigational